Organization | University of Illinois

University of Illinois Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Champaign IL United States (1867)

Organization Overview

First Clinical Trial

2000

NCT00006482

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Department of Kinesiology and Community Health, College of Applied Health Sciences, University of Illinois at Urbana-Champaign | Division of Nutritional Sciences, University of Illinois at Urbana-Champaign | Kenneth Wilund | Kinesiology & Community Health, UIUC | UIUC | University of Illinois at Urbana-Champaign | University of Illinois at Urbana-Champaign, Department of Kinesiology | University of Illinois College of Medicine at Peoria | University of Illinois Department of Surgical Oncology | University of Illinois Urbana Champaign | University of Illinois Urbana-Champaign | University of Illinois Urbana Champaign School of Social Work

Active Ingredients

Drugs in Phase 4 Trials (15)

acetaminophen (tylenol) (1 trial)

acetylsalicylic acid (aspirin) (2 trials)

bupivacaine (Exparel) (1 trial)

fentanyl (Innovar) (1 trial)

gabapentin (neurontin) (1 trial)

hydrocodone (hycodan) (1 trial)

hydromorphone (diladid) (1 trial)

ketamine (ketalar) (1 trial)

ketorolac (acuvail) (1 trial)

levobupivacaine (chirocaine) (1 trial)

lidocaine (xylocaine) (1 trial)

methadone (methadose) (1 trial)

morphine (1 trial)

orphenadrine hydrochloride (disipal) (1 trial)

tramadol (Ultram) (1 trial)

Drugs in Phase 3 Trials (1)

metformin (glucophage) (1 trial)

Drugs in Phase 2 Trials (6)

cisplatin (platinol) (2 trials)

etanercept (enbrel) (1 trial)

gemcitabine (gemzar) (2 trials)

icosapent ethyl (vascepa) (1 trial)

ranibizumab (lucentis) (1 trial)

vitamin d3 (2 trials)

Drugs in Phase 1 Trials (8)

ceftaroline fosamil (teflaro) (1 trial)

doripenem (doribax) (1 trial)

ethanol (3 trials)

inulin (2 trials)

maltodextrin (3 trials)

sargramostim (leukine) (1 trial)

whey protein (2 trials)

Drugs in Other Trials (26)

almond (1 trial)

avocado (2 trials)

bc006 (1 trial)

beta-hydroxyisovaleric acid (1 trial)

bifidobacterium animalis (2 trials)

citrulline (1 trial)

cocoa flavanols (1 trial)

corn (2 trials)

cow milk (5 trials)

dextrose (1 trial)

dileucine (1 trial)

fiber (1 trial)

fructo-oligosaccharide (2 trials)

galactooligosaccharide (1 trial)

honey (1 trial)

hydroxymethylbutyrate (1 trial)

leucine (2 trials)

lutein (1 trial)

palmitic acid (1 trial)

pomegranate (1 trial)

potato (1 trial)

risperidone (risperdal) (1 trial)

salmon (1 trial)

sucrose (1 trial)

walnut (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Pain (Phase 4)

Angioid Streaks (Phase 2)

Bone Diseases (Phase 1)

Bone Diseases, Endocrine (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 2)

Choroidal Neovascularization (Phase 2)

Chronic Disease (Phase 3)

Colonic Neoplasms (Phase 4)

Colorectal Neoplasms (Phase 2)

Constipation (Phase 4)

Diverticulitis (Phase 4)

Diverticulitis, Colonic (Phase 4)

Diverticulum (Phase 4)

Endocrine System Diseases (Phase 1)

Fatty Liver (Phase 2)

Hypersensitivity (Phase 3)

Ileus (Phase 4)

Insulin Resistance (Phase 3)

Metabolic Diseases (Phase 1)

Metabolic Syndrome (Phase 1)

Muscle Weakness (Phase 1)

Myasthenia Gravis (Phase 1)

Neoplasms (Phase 4)

Neovascularization, Pathologic (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Ovarian Neoplasms (Phase 2)

Pain, Postoperative (Phase 4)

Rectal Neoplasms (Phase 4)

Rib Fractures (Phase 4)

Tinnitus (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Weight Loss (Phase 1)

Wounds and Injuries (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 50
# of Trial APIs: 56